Monoamine oxidases in development

[1]  M. Webster,et al.  Developmental changes in human dopamine neurotransmission: cortical receptors and terminators , 2012, BMC Neuroscience.

[2]  A. Mattevi,et al.  The ‘gating’ residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition , 2011, The FEBS journal.

[3]  R. Brigelius-Flohé,et al.  Basic principles and emerging concepts in the redox control of transcription factors. , 2011, Antioxidants & redox signaling.

[4]  P. F. Fitzpatrick,et al.  Structures and mechanism of the monoamine oxidase family , 2011, Biomolecular concepts.

[5]  Š. Čikoš,et al.  Biogenic monoamines in preimplantation development. , 2011, Human reproduction.

[6]  J. Doorn,et al.  Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite. , 2011, Neurotoxicology.

[7]  W. Severt,et al.  Disease Modification in Parkinson’s Disease , 2011, Drugs & aging.

[8]  J. Martinou,et al.  Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. , 2011, Developmental cell.

[9]  Roberta Menabò,et al.  Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. , 2011, Biochimica et biophysica acta.

[10]  C. Ufer,et al.  Monoamine Oxidase A Expression Is Vital for Embryonic Brain Development by Modulating Developmental Apoptosis* , 2011, The Journal of Biological Chemistry.

[11]  J. Doorn,et al.  Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-Quinone* , 2011, The Journal of Biological Chemistry.

[12]  J. Franklin Redox regulation of the intrinsic pathway in neuronal apoptosis. , 2011, Antioxidants & redox signaling.

[13]  M. Crair,et al.  How do barrels form in somatosensory cortex? , 2011, Annals of the New York Academy of Sciences.

[14]  W. A. van der Donk,et al.  Cyclooxygenase reaction mechanism of prostaglandin H synthase from deuterium kinetic isotope effects. , 2011, Journal of inorganic biochemistry.

[15]  J. Shih,et al.  Transcriptional regulation and multiple functions of MAO genes , 2011, Journal of Neural Transmission.

[16]  Per Svenningsson,et al.  Modulation of monoamine receptors by adaptor proteins and lipid rafts: role in some effects of centrally acting drugs and therapeutic agents. , 2011, Annual review of pharmacology and toxicology.

[17]  M. Norenberg,et al.  Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal. , 2010, Biochemical pharmacology.

[18]  K. Mohanakumar,et al.  2-Phenylethylamine, a constituent of chocolate and wine, causes mitochondrial complex-I inhibition, generation of hydroxyl radicals and depletion of striatal biogenic amines leading to psycho-motor dysfunctions in Balb/c mice , 2010, Neurochemistry International.

[19]  F. Turturro,et al.  Troglitazone Regulates Anaplerosis via a Pull/Push Affect on Glutamate Dehydrogenase Mediated Glutamate Deamination in Kidney-derived Epithelial Cells; Implications for the Warburg Effect , 2010, Cellular Physiology and Biochemistry.

[20]  M. Mattson,et al.  Monoamine Oxidases Regulate Telencephalic Neural Progenitors in Late Embryonic and Early Postnatal Development , 2010, The Journal of Neuroscience.

[21]  S. Rybárová,et al.  Impact of 2 Doses of Clorgyline on the Rat Preimplantation Embryo Development and the Monoamine Levels in Urine , 2010, Reproductive Sciences.

[22]  C. Ufer,et al.  Redox control in mammalian embryo development. , 2010, Antioxidants & redox signaling.

[23]  D. S. St. Clair,et al.  Manganese superoxide dismutase versus p53: the mitochondrial center , 2010, Annals of the New York Academy of Sciences.

[24]  K. Schulten,et al.  O2 Reactivity of Flavoproteins , 2010, The Journal of Biological Chemistry.

[25]  J. Fowler,et al.  Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches , 2010, Epigenetics.

[26]  O. Spigset,et al.  Triptan Exposure During Pregnancy and the Risk of Major Congenital Malformations and Adverse Pregnancy Outcomes: Results From The Norwegian Mother and Child Cohort Study , 2010, Headache.

[27]  K. Broadley The vascular effects of trace amines and amphetamines. , 2010, Pharmacology & therapeutics.

[28]  H. Forman,et al.  Signaling functions of reactive oxygen species. , 2010, Biochemistry.

[29]  P. Gaspar,et al.  New perspectives on the neurodevelopmental effects of SSRIs. , 2010, Trends in pharmacological sciences.

[30]  F. Artigas,et al.  Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex. , 2010, Current pharmaceutical design.

[31]  A. Parini,et al.  Characterization of monoamine oxidases in mesenchymal stem cells: role in hydrogen peroxide generation and serotonin-dependent apoptosis. , 2010, Stem cells and development.

[32]  D. Mousseau,et al.  Serine 209 resides within a putative p38(MAPK) consensus motif and regulates monoamine oxidase‐A activity , 2009, Journal of neurochemistry.

[33]  Amy L. Salisbury,et al.  Fetal effects of psychoactive drugs. , 2009, Clinics in perinatology.

[34]  L. Pollegioni,et al.  Optimization of d‐amino acid oxidase for low substrate concentrations – towards a cancer enzyme therapy , 2009, The FEBS journal.

[35]  J. Mallet,et al.  Mammalian prenatal development: the influence of maternally derived molecules , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[36]  Yun-Fai Chris Lau,et al.  Regulation of monoamine oxidase A by the SRY gene on the Y chromosome , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  D. Mousseau,et al.  Calcium alters monoamine oxidase-A parameters in human cerebellar and rat glial C6 cell extracts: possible influence by distinct signalling pathways. , 2009, Life sciences.

[38]  A. Mattevi,et al.  Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases. , 2009, Biochemistry.

[39]  X. Ou,et al.  Retinoic Acid Activates Monoamine Oxidase B Promoter in Human Neuronal Cells* , 2009, The Journal of Biological Chemistry.

[40]  L. Fattore,et al.  The Roman High- and Low-Avoidance Rat Lines Differ in the Acquisition, Maintenance, Extinction, and Reinstatement of Intravenous Cocaine Self-Administration , 2009, Neuropsychopharmacology.

[41]  O. Kellermann,et al.  Computational approaches for the study of serotonin and its membrane transporter SERT: implications for drug design in neurological sciences. , 2008, Current medicinal chemistry.

[42]  B. Casslén,et al.  Monoamine transporters in human endometrium and decidua. , 2008, Human reproduction update.

[43]  T. Lanthorn,et al.  Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants , 2008, PloS one.

[44]  J. Shih,et al.  Monoamine oxidase inactivation: from pathophysiology to therapeutics. , 2008, Advanced drug delivery reviews.

[45]  S. Zanella,et al.  Prenatal activation of 5‐HT2A receptor induces expression of 5‐HT1B receptor in phrenic motoneurons and alters the organization of their premotor network in newborn mice , 2008, The European journal of neuroscience.

[46]  A. Witte,et al.  The role of serotonin in intestinal luminal sensing and secretion , 2008, Acta physiologica.

[47]  K. Haginoya,et al.  β-Phenylethylamine Inhibits K+ Currents in Neocortical Neurons of the Rat: A Possible Mechanism of β-phenylethylamine-induced Seizures , 2008 .

[48]  M. Smidt,et al.  Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities , 2008, PloS one.

[49]  I. Wierstra,et al.  Sp1: emerging roles--beyond constitutive activation of TATA-less housekeeping genes. , 2008, Biochemical and biophysical research communications.

[50]  R. Corradetti,et al.  Sporadic Autonomic Dysregulation and Death Associated with Excessive Serotonin Autoinhibition , 2008, Science.

[51]  C. Ufer,et al.  Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development. , 2008, Genes & development.

[52]  Carol A. Mason,et al.  Retinal axon growth at the optic chiasm: to cross or not to cross. , 2008, Annual review of neuroscience.

[53]  M. Mareková,et al.  Study of high deprenyl dose on the preimplantation embryo development and lymphocyte DNA in rat. , 2008, General physiology and biophysics.

[54]  J. Shih,et al.  Novel monoamine oxidase A knock out mice with human-like spontaneous mutation , 2008, Neuroreport.

[55]  R. Chaerkady,et al.  Serotonin in pre-implantation mouse embryos is localized to the mitochondria and can modulate mitochondrial potential. , 2008, Reproduction.

[56]  E. Yamashita,et al.  Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors , 2008, Proceedings of the National Academy of Sciences.

[57]  G. Desir,et al.  Catecholamines Regulate the Activity, Secretion, and Synthesis of Renalase , 2008, Circulation.

[58]  Dennis L. Murphy,et al.  Targeting the murine serotonin transporter: insights into human neurobiology , 2008, Nature Reviews Neuroscience.

[59]  J. Freed,et al.  Determination of the oligomeric states of human and rat monoamine oxidases in the outer mitochondrial membrane and octyl beta-D-glucopyranoside micelles using pulsed dipolar electron spin resonance spectroscopy. , 2008, Biochemistry.

[60]  C. Ufer,et al.  Monoamine oxidase‐A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells , 2007, Journal of neurochemistry.

[61]  N. Rasgon,et al.  Mood disorders and fertility in women: a critical review of the literature and implications for future research. , 2007, Human reproduction update.

[62]  Angelo Carotti,et al.  Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. , 2007, Journal of medicinal chemistry.

[63]  W. Webster,et al.  The effect of hypoxia in development. , 2007, Birth defects research. Part C, Embryo today : reviews.

[64]  P. Pelicci,et al.  Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? , 2007, Nature Reviews Molecular Cell Biology.

[65]  Hermann-Georg Holzhütter,et al.  Molecular dioxygen enters the active site of 12/15-lipoxygenase via dynamic oxygen access channels , 2007, Proceedings of the National Academy of Sciences.

[66]  Š. Čikoš,et al.  Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes. , 2007, Reproduction.

[67]  J. Mialet-Perez,et al.  New insights on receptor-dependent and monoamine oxidase-dependent effects of serotonin in the heart , 2007, Journal of Neural Transmission.

[68]  M. Blue,et al.  Neonatal serotonin depletion alters behavioral responses to spatial change and novelty , 2007, Brain Research.

[69]  P. Gaspar,et al.  Developmental Cell Death Is Enhanced in the Cerebral Cortex of Mice Lacking the Brain Vesicular Monoamine Transporter , 2007, The Journal of Neuroscience.

[70]  J. Mallet,et al.  Maternal serotonin is crucial for murine embryonic development , 2007, Proceedings of the National Academy of Sciences.

[71]  J. Hansen Oxidative stress as a mechanism of teratogenesis. , 2006, Birth defects research. Part C, Embryo today : reviews.

[72]  K. Itoh,et al.  Substrate selectivity of monoamine oxidase A, monoamine oxidase B, diamine oxidase, and semicarbazide-sensitive amine oxidase in COS-1 expression systems. , 2006, Biological & pharmaceutical bulletin.

[73]  L. Dwoskin,et al.  Vesicular monoamine transporter 2: Role as a novel target for drug development , 2006, The AAPS Journal.

[74]  H. Sørensen,et al.  Maternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations , 2006, Epidemiology.

[75]  N. Freemantle,et al.  Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. , 2006, Archives of general psychiatry.

[76]  Y. Larmet,et al.  Unraveling in vivo Functions of Amyloid Precursor Protein: Insights from Knockout and Knockdown Studies , 2006, Neurodegenerative Diseases.

[77]  R. Carroll,et al.  Plasma serotonin in autism. , 2006, Pediatric neurology.

[78]  X. Ou,et al.  Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[79]  M. Levin,et al.  Of Minds and Embryos: Left-Right Asymmetry and the Serotonergic Controls of Pre-Neural Morphogenesis , 2006, Developmental Neuroscience.

[80]  Mark Walker,et al.  Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. , 2006, American journal of obstetrics and gynecology.

[81]  B. Strassmann,et al.  Cortisol levels and very early pregnancy loss in humans. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[82]  S. Hernández-Díaz,et al.  Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn , 2006, The New England journal of medicine.

[83]  Sheldon Magder,et al.  Reactive oxygen species: toxic molecules or spark of life? , 2006, Critical care.

[84]  J. Greer,et al.  Preparing for the first breath: prenatal maturation of respiratory neural control , 2006, The Journal of physiology.

[85]  M. Morishima,et al.  Monoamine Oxidase A Activity and Norepinephrine Level in Hippocampus Determine Hyperwheel Running in SPORTS Rats , 2006, Neuropsychopharmacology.

[86]  R. Seger,et al.  The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions , 2006, Growth factors.

[87]  P. Amireault,et al.  Intracellular cAMP and Calcium Signaling by Serotonin in Mouse Cumulus-Oocyte Complexes , 2005, Molecular Pharmacology.

[88]  Andrea Mattevi,et al.  Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[89]  P. Amireault,et al.  Serotonin and Its Antidepressant-Sensitive Transport in Mouse Cumulus-Oocyte Complexes and Early Embryos1 , 2005, Biology of reproduction.

[90]  Yan A. Su,et al.  Monoamine oxidase‐A is a major target gene for glucocorticoids in human skeletal muscle cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[91]  H. Kuhn,et al.  Expression regulation of MAO isoforms in monocytic cells in response to Th2 cytokines. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[92]  Š. Čikoš,et al.  Expression of beta adrenergic receptors in mouse oocytes and preimplantation embryos , 2005, Molecular reproduction and development.

[93]  T. Einarson,et al.  Antidepressant Use during Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis , 2005, The Annals of pharmacotherapy.

[94]  A. Mattevi,et al.  Demonstration of Isoleucine 199 as a Structural Determinant for the Selective Inhibition of Human Monoamine Oxidase B by Specific Reversible Inhibitors* , 2005, Journal of Biological Chemistry.

[95]  J. Gautier,et al.  From oogenesis through gastrulation: developmental regulation of apoptosis. , 2005, Seminars in cell & developmental biology.

[96]  S. Choi,et al.  R1, a Novel Repressor of the Human Monoamine Oxidase A* , 2005, Journal of Biological Chemistry.

[97]  J. Haavik,et al.  Different properties of the central and peripheral forms of human tryptophan hydroxylase , 2005, Journal of neurochemistry.

[98]  B. Gutiérrez,et al.  Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders , 2004, Psychiatric genetics.

[99]  N. Scrutton Chemical aspects of amine oxidation by flavoprotein enzymes. , 2004, Natural product reports.

[100]  H. Lagercrantz,et al.  Development of neurotransmitter systems during critical periods , 2004, Experimental Neurology.

[101]  J. Fitzgerald,et al.  Th2 Response of Human Peripheral Monocytes Involves Isoform-Specific Induction of Monoamine Oxidase-A12 , 2004, The Journal of Immunology.

[102]  A. Doseff Apoptosis: the sculptor of development. , 2004, Stem cells and development.

[103]  J. Shih,et al.  A Spontaneous Point Mutation Produces Monoamine Oxidase A/B Knock-out Mice with Greatly Elevated Monoamines and Anxiety-like Behavior*♦ , 2004, Journal of Biological Chemistry.

[104]  Š. Čikoš,et al.  Serotonin localization and its functional significance during mouse preimplantation embryo development , 2004, Zygote.

[105]  L. Maffei,et al.  ERK signaling is required for eye-specific retino-geniculate segregation , 2004, Development.

[106]  A. Mattevi,et al.  Structure and mechanism of monoamine oxidase. , 2004, Current medicinal chemistry.

[107]  B. Levy,et al.  Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. , 2004, The American journal of psychiatry.

[108]  J. Mallet,et al.  Recent advances in understanding serotonin regulation of cardiovascular function. , 2004, Trends in molecular medicine.

[109]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[110]  Masato Yoshimura,et al.  Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. , 2004, Journal of molecular biology.

[111]  A. Petros,et al.  Structural biology of the Bcl-2 family of proteins. , 2004, Biochimica et biophysica acta.

[112]  J. Medina,et al.  Mitochondrial extracellular signal‐regulated kinases 1/2 (ERK1/2) are modulated during brain development , 2004, Journal of neurochemistry.

[113]  P. Gaspar,et al.  The developmental role of serotonin: news from mouse molecular genetics , 2003, Nature Reviews Neuroscience.

[114]  V. Arango,et al.  Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice , 2003, Biological Psychiatry.

[115]  D. Murphy,et al.  Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression , 2003, Biological Psychiatry.

[116]  J. Mallet,et al.  Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[117]  M. Bader,et al.  A unique central tryptophan hydroxylase isoform. , 2003, Biochemical pharmacology.

[118]  W. K. Wong,et al.  Decreased Methylation and Transcription Repressor Sp3 Up-regulated Human Monoamine Oxidase (MAO) B Expression during Caco-2 Differentiation* , 2003, Journal of Biological Chemistry.

[119]  Andrea Mattevi,et al.  Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[120]  L. Altshuler,et al.  Placental passage of antidepressant medications. , 2003, The American journal of psychiatry.

[121]  D. Murphy,et al.  Reduced programmed cell death in brains of serotonin transporter knockout mice , 2003, Neuroreport.

[122]  T. Branchek,et al.  Trace amine receptors as targets for novel therapeutics: legend, myth and fact. , 2003, Current opinion in pharmacology.

[123]  H. Imai,et al.  Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. , 2003, Free radical biology & medicine.

[124]  N. Pellegrini,et al.  Selected methodologies to assess oxidative/antioxidant status in vivo: a critical review. , 2002, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[125]  Chi-Wai Wong,et al.  Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[126]  P. Gaspar,et al.  Refinement of Thalamocortical Arbors and Emergence of Barrel Domains in the Primary Somatosensory Cortex: A Study of Normal and Monoamine Oxidase A Knock-Out Mice , 2002, The Journal of Neuroscience.

[127]  Neal Castagnoli,et al.  8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism* , 2002, The Journal of Biological Chemistry.

[128]  D. Melton,et al.  "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells , 2002, Science.

[129]  Wim E Crusio,et al.  Knockout mice: simple solutions to the problems of genetic background and flanking genes , 2002, Trends in Neurosciences.

[130]  Luciana Dini,et al.  Cell death: apoptosis versus necrosis (review). , 2002, International journal of oncology.

[131]  O. Kunduzova,et al.  The FASEB Journal express article 10.1096/fj.01-1008fje. Published online May 21, 2002. Regulation of JNK/ERK activation, cell apoptosis, and , 2022 .

[132]  W. K. Wong,et al.  Activation of Human Monoamine Oxidase B Gene Expression by a Protein Kinase C MAPK Signal Transduction Pathway Involves c-Jun and Egr-1* , 2002, The Journal of Biological Chemistry.

[133]  E. Billett,et al.  Monoamine oxidase expression and activity in human placentae from pre-eclamptic and normotensive pregnancies. , 2002, Placenta.

[134]  P. Gaspar,et al.  Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse , 2002, The Journal of comparative neurology.

[135]  G. Killian,et al.  Identification of norepinephrine in bovine oviductal fluid by high performance liquid chromatography. , 2001, Life Science.

[136]  P. Berbel,et al.  Role of thyroid hormones in the maturation and organisation of rat barrel cortex , 2001, Neuroscience.

[137]  J. Raymond,et al.  Multiplicity of mechanisms of serotonin receptor signal transduction. , 2001, Pharmacology & therapeutics.

[138]  H. Lagercrantz,et al.  Neurotransmitters and neuromodulators during early human development. , 2001, Early human development.

[139]  G. Eisenhofer The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. , 2001, Pharmacology & therapeutics.

[140]  G. Buznikov,et al.  Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis , 2001, Cell and Tissue Research.

[141]  J. Bye,et al.  Sequence analysis and transcript identification within 1.5 MB of DNA deleted together with the NDP and MAO genes in atypical Norrie disease patients presenting with a profound phenotype , 2001, Human mutation.

[142]  K. Lesch,et al.  Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. , 2001, American journal of medical genetics.

[143]  Dennis L. Murphy,et al.  Excessive Activation of Serotonin (5-HT) 1B Receptors Disrupts the Formation of Sensory Maps in Monoamine Oxidase A and 5-HT Transporter Knock-Out Mice , 2001, The Journal of Neuroscience.

[144]  D. Edmondson,et al.  Structure-activity relations in the oxidation of phenethylamine analogues by recombinant human liver monoamine oxidase A. , 2000, Biochemistry.

[145]  Hiroshi Nishimaru,et al.  Formation of the central pattern generator for locomotion in the rat and mouse , 2000, Brain Research Bulletin.

[146]  C. Culmsee,et al.  Stimulation of 5-HT1A receptors reduces apoptosis after transient forebrain ischemia in the rat , 2000, Brain Research.

[147]  D. Sorescu,et al.  Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[148]  A. Dierich,et al.  Serotonin 2B receptor is required for heart development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[149]  J. Kauer,et al.  Amphetamine Blocks Long-Term Synaptic Depression in the Ventral Tegmental Area , 2000, The Journal of Neuroscience.

[150]  K. Davies,et al.  Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.

[151]  S. Dey,et al.  Blastocyst H(2) receptor is the target for uterine histamine in implantation in the mouse. , 2000, Development.

[152]  I. Seif,et al.  Abnormal Phrenic Motoneuron Activity and Morphology in Neonatal Monoamine Oxidase A-Deficient Transgenic Mice: Possible Role of a Serotonin Excess , 2000, The Journal of Neuroscience.

[153]  A. Korten,et al.  Association of a functional polymorphism of the monoamine oxidase A gene promoter with personality and psychiatric symptoms. , 2000, Psychiatric genetics.

[154]  H. Lagercrantz,et al.  Prenatal hypoxia impairs the postnatal development of neural and functional chemoafferent pathway in rat , 2000, The Journal of physiology.

[155]  J. Cazalets,et al.  Locomotor network maturation is transiently delayed in the MAOA-deficient mouse. , 2000, Journal of neurophysiology.

[156]  G. Kirov,et al.  A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder. , 1999, The international journal of neuropsychopharmacology.

[157]  R. Palmiter,et al.  Feeding behavior in dopamine-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[158]  A. Giaccia,et al.  Hypoxic microenvironment within an embryo induces apoptosis and is essential for proper morphological development. , 1999, Teratology.

[159]  J. Leysen,et al.  Does phenylethylamine act as an endogenous amphetamine in some patients? , 1999, The international journal of neuropsychopharmacology.

[160]  P. Gaspar,et al.  Excess of Serotonin (5-HT) Alters the Segregation of Ispilateral and Contralateral Retinal Projections in Monoamine Oxidase A Knock-Out Mice: Possible Role of 5-HT Uptake in Retinal Ganglion Cells During Development , 1999, The Journal of Neuroscience.

[161]  M. Kung,et al.  Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A , 1999, Brain Research.

[162]  S. Nanko,et al.  A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders , 1999, Molecular Psychiatry.

[163]  O. Scremin,et al.  Cerebral cortical blood flow maps are reorganized in MAOB-deficient mice , 1999, Brain Research.

[164]  J. Isaac,et al.  Experience-dependent development of NMDA receptor transmission , 1999, Nature Neuroscience.

[165]  J. Parnavelas,et al.  The noradrenergic system influences the fate of Cajal-Retzius cells in the developing cerebral cortex. , 1999, Brain research. Developmental brain research.

[166]  G. Hilaire,et al.  Serotonin levels are abnormally elevated in the fetus of the monoamine oxidase-A-deficient transgenic mouse , 1999, Neuroscience Letters.

[167]  K. Okuda,et al.  Noradrenaline stimulates the production of prostaglandin f2alpha in cultured bovine endometrial cells. , 1999, Biology of reproduction.

[168]  T. Kundu,et al.  CpG islands in chromatin organization and gene expression. , 1999, Journal of biochemistry.

[169]  A. Porter,et al.  Emerging roles of caspase-3 in apoptosis , 1999, Cell Death and Differentiation.

[170]  D. Hamer,et al.  A functional polymorphism in the monoamine oxidase A gene promoter , 1998, Human Genetics.

[171]  S. Hansson,et al.  Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest derivatives and their target sites in the rat. , 1998, Brain research. Developmental brain research.

[172]  P. Gaspar,et al.  Plasma Membrane Transporters of Serotonin, Dopamine, and Norepinephrine Mediate Serotonin Accumulation in Atypical Locations in the Developing Brain of Monoamine Oxidase A Knock-Outs , 1998, The Journal of Neuroscience.

[173]  R. Pendleton,et al.  A new role for catecholamines: ontogenesis. , 1998, Trends in pharmacological sciences.

[174]  N. Kudo,et al.  Development of the spatial pattern of 5-HT-induced locomotor rhythm in the lumbar spinal cord of rat fetuses in vitro , 1998, Neuroscience Research.

[175]  Fei Xu,et al.  Knockout of the Vesicular Monoamine Transporter 2 Gene Results in Neonatal Death and Supersensitivity to Cocaine and Amphetamine , 1997, Neuron.

[176]  Takeshi Kumazawa,et al.  Increased stress response and β–phenylethylamine in MAOB–deficient mice , 1997, Nature Genetics.

[177]  Christine F. Hohmann,et al.  Behavioral consequences of abnormal cortical development: insights into developmental disabilities , 1997, Behavioural Brain Research.

[178]  C. Adams,et al.  D1 and D2Dopamine Receptors in Perinatal and Adult Basal Ganglia , 1997, Pediatric Research.

[179]  M. Fanselow,et al.  Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[180]  L. Zon,et al.  Cdc42Hs, but Not Rac1, Inhibits Serum-stimulated Cell Cycle Progression at G1/S through a Mechanism Requiring p38/RK* , 1997, The Journal of Biological Chemistry.

[181]  G. Cohen,et al.  Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[182]  J. Padbury,et al.  Human placental norepinephrine transporter mRNA: expression and correlation with fetal condition at birth. , 1997, Placenta.

[183]  M. Weinstock Does Prenatal Stress Impair Coping and Regulation of Hypothalamic-Pituitary-Adrenal Axis? , 1997, Neuroscience & Biobehavioral Reviews.

[184]  G. Koren,et al.  Neurodevelopment of children exposed in utero to antidepressant drugs , 1997, The New England journal of medicine.

[185]  S. Stahl,et al.  Mirtazapine: An Antidepressant with Noradrenergic and Specific Serotonergic Effects , 1997, Pharmacotherapy.

[186]  T. Joh,et al.  Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization , 1997, Synapse.

[187]  P. Riederer,et al.  Pharmacology of selegiline , 1996, Neurology.

[188]  D. Broverman,et al.  Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women , 1996, Psychoneuroendocrinology.

[189]  L. Maroteaux,et al.  Immunohistochemical localisation of the serotonin 5‐HT2B receptor in mouse gut, cardiovascular system, and brain , 1996, FEBS letters.

[190]  P. Mastroiacovo,et al.  The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). , 1996, Reproductive toxicology.

[191]  V. Ganapathy,et al.  Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells. , 1996, Placenta.

[192]  A. Blaschke,et al.  Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. , 1996, Development.

[193]  Qingbo Xu,et al.  Activation of Mitogen-activated Protein Kinase by HO , 1996, The Journal of Biological Chemistry.

[194]  J. Shih,et al.  Influence of C Terminus on Monoamine Oxidase A and B Catalytic Activity , 1996, Journal of Neurochemistry.

[195]  P. Malherbe,et al.  Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry , 1996, Neuroscience.

[196]  Patricia Gaspar,et al.  Lack of Barrels in the Somatosensory Cortex of Monoamine Oxidase A–Deficient Mice: Role of a Serotonin Excess during the Critical Period , 1996, Neuron.

[197]  R. Palmiter,et al.  Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic , 1995, Cell.

[198]  V. M. Pickel,et al.  The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[199]  M. Subhash,et al.  Monoamine oxidase isoenzymes in rat brain: Differential changes during postnatal development but not aging , 1995, Neurobiology of Aging.

[200]  J. Launay,et al.  Increased plasma serotonin in primary pulmonary hypertension. , 1995, The American journal of medicine.

[201]  Puchkov Vf,et al.  The effect of a serotonin deficiency on mammalian embryonic development , 1995 .

[202]  J. Padbury,et al.  Placental norepinephrine clearance: in vivo measurement and physiological role. , 1995, The American journal of physiology.

[203]  P. Gaspar,et al.  Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. , 1995, Science.

[204]  P. Malherbe,et al.  Structure/function relationships of mitochondrial monoamine oxidase A and B chimeric forms. , 1995, European journal of biochemistry.

[205]  R. Palmiter,et al.  Noradrenaline is essential for mouse fetal development , 1995, Nature.

[206]  E. Paykel,et al.  Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression , 1995, Acta psychiatrica Scandinavica. Supplementum.

[207]  T. Slotkin,et al.  Cocaine inhibits central noradrenergic and dopaminergic activity during the critical developmental period in which catecholamines influence cell development. , 1995, Brain research. Developmental brain research.

[208]  J. Klinman,et al.  Hydrogen tunneling in the flavoenzyme monoamine oxidase B. , 1994, Biochemistry.

[209]  E. Scarr,et al.  The effects of administration of monoamine oxidase‐B inhibitors on rat striatal neurone responses to dopamine , 1994, British journal of pharmacology.

[210]  Yamamoto Ken-ichi,et al.  Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-κB in vitro , 1994 .

[211]  D. Edmondson,et al.  Structure-activity relationships in the oxidation of benzylamine analogues by bovine liver mitochondrial monoamine oxidase B. , 1994, Biochemistry.

[212]  D. Glanzman Postsynaptic regulation of the development and long-term plasticity of Aplysia sensorimotor synapses in cell culture. , 1994, Journal of neurobiology.

[213]  G. Hilaire,et al.  Involvement of the rostral ventro-lateral medulla in respiratory rhythm genesis during the peri-natal period: an in vitro study in newborn and fetal rats. , 1994, Brain research. Developmental brain research.

[214]  B Fischer,et al.  Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. , 1993, Journal of reproduction and fertility.

[215]  M. Nelen,et al.  Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. , 1993, Science.

[216]  U. Lang,et al.  Systemic and uterine vascular response to serotonin in third trimester pregnant ewes. , 1993, European journal of obstetrics, gynecology, and reproductive biology.

[217]  E. Sundström,et al.  Neurochemical differentiation of human bulbospinal monoaminergic neurons during the first trimester. , 1993, Brain research. Developmental brain research.

[218]  J. Shih,et al.  The Deduced Amino Acid Sequences of Human Platelet and Frontal Cortex Monoamine Oxidase B Are Identical , 1993, Journal of neurochemistry.

[219]  J. Lauder,et al.  Neurotransmitters as growth regulatory signals: role of receptors and second messengers , 1993, Trends in Neurosciences.

[220]  J. Lauder,et al.  Serotonin and cardiac morphogenesis in the mouse embryo. , 1993, Teratology.

[221]  J. Padbury,et al.  Fetal catecholamine, cardiovascular, and neurobehavioral responses to cocaine. , 1992, American journal of obstetrics and gynecology.

[222]  R. Blakely,et al.  Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast. , 1992, Biochemistry.

[223]  E. Soriano,et al.  Cell death and removal in the cerebral cortex during development , 1992, Progress in Neurobiology.

[224]  X. Breakefield,et al.  Structure of the human gene for monoamine oxidase type A. , 1991, Nucleic acids research.

[225]  J. Shih,et al.  Human monoamine oxidase A and B genes exhibit identical exon-intron organization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[226]  I. Seif,et al.  Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment , 1991, Journal of virology.

[227]  R. Neve,et al.  Tissue Distribution of Human Monoamine Oxidase A and B mRNA , 1990, Journal of neurochemistry.

[228]  Markova Ln,et al.  The effect of biogenic monoamine antagonists on the development of preimplantation mouse embryos cultured in vitro , 1990 .

[229]  T. Kuroki,et al.  [beta-Phenylethylamine and amphetamine: similar aspects in their behavioropharmacological and neurochemical characteristics]. , 1989, Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology.

[230]  R. Wiesner,et al.  Oxygenation of mitochondrial membranes by the reticulocyte lipoxygenase. Action on monoamine oxidase activities A and B. , 1989, Biochimica et biophysica acta.

[231]  J. Padbury Functional maturation of the adrenal medulla and peripheral sympathetic nervous system. , 1989, Bailliere's clinical endocrinology and metabolism.

[232]  N. Pratt,et al.  Effects of social stress during early pregnancy on litter size and sex ratio in the golden hamster (Mesocricetus auratus). , 1989, Journal of reproduction and fertility.

[233]  P. Chedrese,et al.  The influence of ovarian hormones on the rat oviductal and uterine concentration of noradrenaline and 5-hydroxytryptamine , 1989, Neurochemical Research.

[234]  T. Segawa,et al.  [5-Hydroxytryptamine receptors]. , 1989, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[235]  Acharya Sb,et al.  Uterine and placental 5-HT profile in different gestational period of albino rats. , 1989 .

[236]  A. Greenshaw,et al.  Reciprocal changes in striatal dopamine and β-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

[237]  R. M. Rose,et al.  Localization of distinct monoamine oxidase a and monoamine oxidase b cell populations in human brainstem , 1988, Neuroscience.

[238]  M. Youdim,et al.  Platelet monoamine oxidase B: Use and misuse , 1988, Experientia.

[239]  A. Colosimo,et al.  A kinetic model for lipoxygenases based on experimental data with the lipoxygenase of reticulocytes. , 1987, European journal of biochemistry.

[240]  W. Künzel,et al.  Redistribution of fetal circulation during repeated asphyxia in sheep: effects on skin blood flow, transcutaneous PO2, and plasma catecholamines. , 1987, Journal of developmental physiology.

[241]  M. Gimeno,et al.  Catecholamines in sow graafian follicles at proestrus and at diestrus. , 1986, Biology of reproduction.

[242]  A. Boulton,et al.  Stereospecific deuterium substitution at the alpha-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues. , 1986, Biochemical pharmacology.

[243]  F. Gusovsky,et al.  Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. , 1986, The Journal of clinical psychiatry.

[244]  Kiyofumi Kobayashi,et al.  Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase , 1984, Neurochemical Research.

[245]  J. Belmar,et al.  Changes in noradrenergic vesicle markers of rabbit oviducts during progesterone treatment. , 1983, Biology of reproduction.

[246]  R. Hammer,et al.  Serotonin-induced disruption of implantation in the rat: II. Suppression of decidualization. , 1983, Biology of reproduction.

[247]  W. Potter,et al.  Temporal association between depression-dependent dyskinesias and high urinary phenylethylamine output. , 1983, Biological Psychiatry.

[248]  G. S. Golden A review of the neuroembryology of monoamine systems , 1982, Brain Research Bulletin.

[249]  N. Sjöberg,et al.  Regional and cyclic variations in catecholamine concentration of the human fallopian tube. , 1982, Biology of reproduction.

[250]  C. Hobel,et al.  Enzymes for epinephrine synthesis and metabolism in the myometrium, endometrium, red blood cells, and plasma of pregnant human subjects. , 1981, American journal of obstetrics and gynecology.

[251]  M. Youdim,et al.  ONTOGENESIS OF UPTAKE AND DEAMINATION OF 5‐HYDROXYTRYPTAMINE, DOPAMINE AND β‐PHENYLETHYLAMINE IN ISOLATED PERFUSED LUNG AND LUNG HOMOGENATES FROM RATS , 1981, British Journal of Pharmacology.

[252]  J. Vliegenthart,et al.  Double dioxygenation of arachidonic acid by soybean lipoxygenase-1. Kinetics and regio-stereo specificities of the reaction steps. , 1981, Biochimica et biophysica acta.

[253]  M. Sandler,et al.  Development of benzylamine oxidase and monoamine oxidase A and B in man. , 1980, Biochemical pharmacology.

[254]  P. Bond,et al.  Properties of monoamine oxidase (MAO) in human blood platelets, plasma, lymphocytes and granulocytes. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[255]  P. Patterson,et al.  The induction of acetylcholine synthesis in primary cultures of dissociated rat sympathetic neurons. I. Effects of conditioned medium. , 1977, Developmental biology.

[256]  C. S. Ramadoss,et al.  Double dioxygenation of arachidonic acid by soybean lipoxygenase--1. , 1977, Biochemical and biophysical research communications.

[257]  F. Bloom,et al.  Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat , 1975, The Journal of comparative neurology.

[258]  Jackson Dm Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors. , 1975 .

[259]  B. Costall,et al.  Dyskinetic phenomena caused by the intrastriatal injection of phenylethylamine, phenylpiperazine, tetrahydroisoquinoline and tetrahydronaphthalene derivatives in the guinea pig. , 1975, European journal of pharmacology.

[260]  F. Bloom,et al.  Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiation , 1974, The Journal of comparative neurology.

[261]  C. Welker Microelectrode delineation of fine grain somatotopic organization of (SmI) cerebral neocortex in albino rat. , 1971, Brain research.

[262]  A. Weissman,et al.  p-Chlorophenylalanine: a specific depletor of brain serotonin. , 1966, The Journal of pharmacology and experimental therapeutics.

[263]  H. Blaschko,et al.  The oxidation of adrenaline and other amines. , 1937, The Biochemical journal.

[264]  Š. Alušík,et al.  Serotonin syndrome. , 2014, Neuro endocrinology letters.

[265]  M Pytliak,et al.  Serotonin receptors - from molecular biology to clinical applications. , 2011, Physiological research.

[266]  K. Haginoya,et al.  Beta-phenylethylamine inhibits K+ currents in neocortical neurons of the rat: a possible mechanism of beta-phenylethylamine-induced seizures. , 2008, Tohoku journal of experimental medicine.

[267]  W. Burke,et al.  Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine. , 2008, Acta neuropathologica.

[268]  Jie Shen,et al.  Gene-targeting technologies for the study of neurological disorders , 2007, NeuroMolecular Medicine.

[269]  D. Wilhelm,et al.  Sex determination and gonadal development in mammals. , 2007, Physiological reviews.

[270]  C. Marsden,et al.  Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease , 2005, Journal of Neural Transmission.

[271]  E. Billett Monoamine oxidase (MAO) in human peripheral tissues. , 2004, Neurotoxicology.

[272]  T. Nagatsu Progress in monoamine oxidase (MAO) research in relation to genetic engineering. , 2004, Neurotoxicology.

[273]  H. Parvez,et al.  Monoamine oxidase expression during development and aging. , 2004, Neurotoxicology.

[274]  M. Grafe,et al.  Transcriptional Regulation of the BCL-X Gene by NF-κB Is an Element of Hypoxic Responses in the Rat Brain , 2004, Neurochemical Research.

[275]  M. Yamada,et al.  Clinical pharmacology of MAO inhibitors: safety and future. , 2004, Neurotoxicology.

[276]  J. Koppel,et al.  Expression of serotonin receptors in mouse oocytes and preimplantation embryos. , 2003, Physiological research.

[277]  Moussa B. H. Youdim,et al.  Neuroprotective Strategies in Parkinson’s Disease , 2003, CNS drugs.

[278]  Andrea Mattevi,et al.  Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders , 2002, Nature Structural Biology.

[279]  A. Parini,et al.  Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase. , 2001, Kidney international.

[280]  J. Shih,et al.  Monoamine oxidase: from genes to behavior. , 1999, Annual review of neuroscience.

[281]  J. Padbury,et al.  Placental biogenic amine transporters: in vivo function, regulation and pathobiological significance. , 1999, Placenta.

[282]  J. Shih,et al.  Increased stress response and beta-phenylethylamine in MAOB-deficient mice. , 1997, Nature genetics.

[283]  J. Padbury,et al.  The contribution of transporter-dependent uptake to fetal catecholamine clearance. , 1997, Biology of the neonate.

[284]  G. Chouinard,et al.  Moclobemide Update of its Pharmacological Properties and Therapeutic Use , 1996 .

[285]  H. Lagercrantz,et al.  Expression of c-fos, Tyrosine Hydroxylase, and Neuropeptide mRNA in the Rat Brain around Birth: Effects of Hypoxia and Hypothermia , 1995, Pediatric Research.

[286]  H. Leese Metabolic control during preimplantation mammalian development. , 1995, Human reproduction update.

[287]  V. Otellin,et al.  [The effect of a serotonin deficiency on mammalian embryonic development]. , 1995, Ontogenez.

[288]  A. Cesura,et al.  The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission. , 1995, Journal of neural transmission. Supplementum.

[289]  K. Mitomo,et al.  Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. , 1994, Gene.

[290]  D. Murphy,et al.  Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. , 1992, American journal of medical genetics.

[291]  L. Markova,et al.  [The effect of biogenic monoamine antagonists on the development of preimplantation mouse embryos cultured in vitro]. , 1990, Zhurnal evoliutsionnoi biokhimii i fiziologii.

[292]  A. Boulton,et al.  Phenylethylamine in the CNS: effects of monoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission. , 1990, Journal of neural transmission. Supplementum.

[293]  S. Acharya,et al.  Uterine and placental 5-HT profile in different gestational period of albino rats. , 1989, Indian journal of experimental biology.

[294]  C. Thibault,et al.  Catecholamines within the rabbit oviduct at fertilization time. , 1987, Human Reproduction.

[295]  M. Youdim,et al.  Monoamine oxidase B inhibition and the "cheese effect". , 1987, Journal of neural transmission. Supplementum.

[296]  V. Rubio,et al.  Human carbamoylphosphate synthetase I. , 1981, Enzyme.

[297]  J. Lauder,et al.  Roles for serotonin in neuroembryogenesis. , 1981, Advances in experimental medicine and biology.

[298]  S. Potkin,et al.  Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls. , 1980, Psychopharmacology bulletin.

[299]  Budantsev AIu,et al.  [Effect of beta-phenylethylamine on the dopaminergic system of rat brain]. , 1979 .

[300]  J. Lauder,et al.  Serotonin as a differentiation signal in early neurogenesis. , 1978, Developmental neuroscience.

[301]  C. Bachmann,et al.  Enzymes of ammonia detoxication after portacaval shunt in the rat. I. Carbamylphosphate synthetase and aspartate transcarbamylase. , 1977, Enzyme.

[302]  D. Jackson Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors. , 1975, Arzneimittel-Forschung.

[303]  V. Hamburger,et al.  Prenatal development of spontaneous and evoked activity in the rat (Rattus norvegicus albinus). , 1971, Behaviour.